Frequent lymphadenopathy
p < 0,001
|
6 (20.0%)
|
0 (0.0%)
|
8 (50.0%)
|
0 (0.0%)
|
Frequent events of sickness/infections
p < 0,001
|
12 (40.0%)
|
3 (10.0%)
|
14 (87.5%)
|
0 (0.0%)
|
Frequent sore throat
p < 0,001
|
9 (30.0%)
|
2 (6.7%)
|
11 (68.8%)
|
0 (0.0%)
|
Hypermobility
p = 0,106
|
10 (33.3%)
|
3 (10.0%)
|
5 (31.3%)
|
5 (16.7%)
|
Any prior GI symptoms
p = 0,001
|
15 (50.0%)
|
6 (20.0%)
|
3 (18.8%)
|
2 (6.7%)
|
Diarrhea
p = 0,068
|
4 (13.3%)
|
0 (0.0%)
|
0 (0.0%)
|
1 (3.3%)
|
Constipation
p = 0,016
|
5 (16.7%)
|
0 (0.0%)
|
1 (6.3%)
|
0 (0.0%)
|
Emesis
p = 0,471
|
1 (3.3%)
|
0 (0.0%)
|
0 (0.0%)
|
0 (0.0%)
|
Bloating
p = 0,021
|
5 (16.7%)
|
1 (3.3%)
|
0 (0.0%)
|
0 (0.0%)
|
Abdominal pain
P = 0,552
|
2 (6.7%)
|
2 (6.7%)
|
1 (6.3%)
|
0 (0.0%)
|
Stool irregularities
p = 0,165
|
0 (0.0%)
|
2 (6.7%)
|
0 (0.0%)
|
0 (0.0%)
|
Reflux
p = 0,176
|
3 (10.0%)
|
1 (3.3%)
|
0 (0.0%)
|
0 (0.0%)
|
Comorbidities
|
PCS
|
SARS-CoV-2, convalescent
|
ME/CFS
|
Healthy
|
Allergies (any)
p = 0,758
|
9 (30.0%)
|
9 (30.0%)
|
7 (43.8%)
|
9 (30.0%)
|
Food intolerance (any)
p <0,001
|
13 (43.3%)
|
4 (13.3%)
|
13 (81.3%)
|
3 (10.0%)
|
Hypercholesterolemia
p = 0,717
|
2 (6.7%)
|
1 (3.3%)
|
0 (0.0%)
|
1 (3.3%)
|
Thyroid diseases
p = 0,309
|
5 (16.7%)
|
1 (3.3%)
|
2 (12.5%)
|
2 (6.7%)
|
POTS
p <0,001
|
0 (0%)
|
0 (0.0%)
|
6 (37.5%)
|
0 (0.0%)
|
EBV-infection confirmed by laboratory diagnostics before study inclusion
p <0,001
|
2 (6.7%)
|
0 (0.0%)
|
10 (62.5%)
|
0 (0.0%)
|